Browse Pet Safety Reports
16,682 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,682 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,682 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jan 24, 2020 | Human | Unknown | Selamectin | Burning mouth sensation | Outcome Unknown |
| Jan 24, 2020 | Human | Unknown | Melarsomine Dihydrochloride | Skin irritation; Accidental exposure | Outcome Unknown |
| Jan 22, 2020 | Human | Unknown | Selamectin | Headache; Localised rash | Outcome Unknown |
| Jan 21, 2020 | Human | Unknown | Phenylpropropanolamine Hcl | Constipation; Hypertension; Stomach upset | Recovered/Normal |
| Jan 21, 2020 | Human | Unknown | Genta/Momet/Clotrim Ear Oint | Application site reaction NOS; Application site burning sensation; Impaired h... | Recovered/Normal |
| Jan 21, 2020 | Human | Unknown | Fluralaner Chew Tablets | Bad taste; Product problem; Product Defect, General | Ongoing |
| Jan 20, 2020 | Human | Unknown | Tilmicosin | Unexplained death | Died |
| Jan 20, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Closure, Abnormal; Dispenser, Abnormal; Dif... | Recovered/Normal |
| Jan 17, 2020 | Human | Unknown | Tiletamine Hcl;Zolazapam Hcl | Reddening of the skin; Nausea; Headache; Mental impairment NOS | Recovered/Normal |
| Jan 17, 2020 | Human | Unknown | Imidacloprid; Moxidectin | Application site irritation; Application site burning sensation; Application ... | Outcome Unknown |
| Jan 17, 2020 | Human | Unknown | Enrofloxacin | Injection site oedema; Nausea; Headache; Injection site bruising; Injection s... | Outcome Unknown |
| Jan 17, 2020 | Human | Unknown | Pimobendan | Light headedness | Recovered/Normal |
| Jan 16, 2020 | Human | Unknown | Phytosphingosine Hydrochloride | Application site pruritus; Application site rash; Pruritic rash | Recovered/Normal |
| Jan 16, 2020 | Human | Unknown | Enrofloxacin | Eye irritation; Eye redness; Periorbital oedema | Outcome Unknown |
| Jan 16, 2020 | Human | Unknown | Tilmicosin | Burning sensation of eye; Bad taste; Accidental exposure | Recovered/Normal |
| Jan 15, 2020 | Human | Unknown | Moxidectin | Injection site lesion | Recovered/Normal |
| Jan 14, 2020 | Human | Unknown | Moxidectin | Wound | Outcome Unknown |
| Jan 14, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Influenza-like symptoms; Emesis (multiple); Lethargy (see also Central nervou... | Ongoing |
| Jan 13, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Jan 13, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Jan 12, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use | Outcome Unknown |
| Jan 11, 2020 | Human | Unknown | Cyclosporine | Light headedness; Stomach upset; Accidental exposure | Recovered/Normal |
| Jan 10, 2020 | Human | Unknown | Imidacloprid; Moxidectin | Tingling sensation | Recovered/Normal |
| Jan 10, 2020 | Human | Unknown | Imidacloprid; Moxidectin | Eye irritation; Application site numbness | Recovered/Normal |
| Jan 9, 2020 | Human | Unknown | Milbemycin Oxime; Lufenuron | Urticarial erythema; Anaphylactic-type reaction | Outcome Unknown |
| Jan 8, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Tubes, Leaking | Recovered/Normal |
| Jan 7, 2020 | Human | Unknown | Mirtazapine | Taste alteration; Localised numbness (see also application site SOC) | Recovered/Normal |
| Jan 7, 2020 | Human | Unknown | Selamectin | Stinging skin; Skin warmth | Recovered/Normal |
| Jan 5, 2020 | Human | Unknown | Clomipramine | Not eating; Not drinking; Abnormal behaviour NOS | Recovered/Normal |
| Jan 4, 2020 | Human | Unknown | Imidacloprid; Moxidectin | Application site tingling | Recovered/Normal |
| Jan 3, 2020 | Human | Unknown | Oxytetracycline Dihydrate (Oxytetracy... | Puncture wound; Injection site numbness; Localised pain NOS (see other 'SOCs'... | Outcome Unknown |
| Jan 1, 2020 | Human | Unknown | Tilmicosin | Death | Died |
| Dec 31, 2019 | Human | Unknown | Oclacitinib Maleate | Diarrhoea | Recovered/Normal |
| Dec 30, 2019 | Human | Unknown | Insulin Injectable Vial | Wound; Appearance, Abnormal; Containers, Leaking; Vials, Abnormal | Ongoing |
| Dec 30, 2019 | Human | Unknown | Trenbolone Acet/Estrad Sr Imp | Injection site swelling; Injection site pain; Puncture wound | Ongoing |
| Dec 27, 2019 | Human | Unknown | Tilmicosin | Feeling anxious | Outcome Unknown |
| Dec 24, 2019 | Human | Unknown | Selamectin | Hives (see also 'Skin'); Generalised rash; Pruritus; Anaphylactic-type reaction | Ongoing |
| Dec 21, 2019 | Human | Unknown | Desoxycorticosterone Pivalate | Eye irritation; Medication error | Outcome Unknown |
| Dec 20, 2019 | Human | Unknown | Enrofloxacin | Injection site pain; Injection site swelling; Injection site bruising | Outcome Unknown |
| Dec 20, 2019 | Human | Unknown | Doramectin | Puncture wound; Injection site bleeding; Immediate pain upon injection; Injec... | Outcome Unknown |
| Dec 20, 2019 | Human | Unknown | Ceftiofur Crystalline Free Acid | Puncture wound; Localised pain NOS (see other 'SOCs' for specific pain) | Outcome Unknown |
| Dec 19, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Dec 19, 2019 | Human | Unknown | Gamithromycin | Tingling sensation; Injection site swelling; Injection site pain; Injection s... | Recovered/Normal |
| Dec 19, 2019 | Human | Unknown | Moxidectin | Eye irritation | Recovered/Normal |
| Dec 18, 2019 | Human | Unknown | Doramectin | Injection site reddening; Injection site pain | Outcome Unknown |
| Dec 18, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Dec 17, 2019 | Human | Unknown | Cyclosporine | Ocular burn; Dry eye; Sore eye | Ongoing |
| Dec 17, 2019 | Human | Unknown | Oclacitinib Maleate | Generalised itching; Female reproductive tract disorder NOS | Outcome Unknown |
| Dec 17, 2019 | Human | Unknown | Moxidectin | Injection site pain; Accidental exposure | Outcome Unknown |
| Dec 16, 2019 | Human | Unknown | Selamectin | Local swelling (not application site); Puncture wound; Dizziness | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.